Related Experiment Video

Updated: Jun 25, 2025

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.0K

The nuclear export protein exportin-1 in solid malignant tumours: From biology to clinical trials

Chuanxi Lai1,2, Lingna Xu1,2, Sheng Dai1,2

  • 1Department of Colorectal Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Clinical and Translational Medicine
|May 24, 2024
PubMed
Abstract

Insights

Exportin-1 (XPO1) inhibitors show promise for treating solid tumors by blocking nuclear export. Further research is needed to optimize their use and identify patient response biomarkers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Exportin-1 (XPO1) is overexpressed in various cancers, driving tumor progression and resistance.
  • XPO1 regulates nuclear-cytoplasmic transport, making it a therapeutic target.
  • Existing XPO1 inhibitors have shown success in hematological malignancies, but their use in solid tumors requires further investigation.

Purpose of the Study:

  • To review the efficacy of XPO1 inhibitors in preclinical and clinical studies of solid tumors.
  • To summarize the mechanism of action, therapeutic potential, and adverse effects of XPO1 inhibitors.
  • To highlight ongoing research and the need for biomarkers in solid tumor treatment.

Main Methods:

  • Comprehensive literature review of XPO1 inhibitors in solid tumors.
  • Analysis of preclinical and clinical trial data.
  • Summary of XPO1's role in cancer and inhibitor mechanisms.

Main Results:

  • XPO1 inhibitors demonstrate therapeutic potential in a range of solid tumors.
  • Clinical trials show varying responses and identified adverse effects.
  • Mechanism of action involves inhibiting XPO1's nuclear export function.

Conclusions:

  • XPO1 inhibition is a promising strategy for solid tumors, offering a novel approach to overcome drug resistance.
  • SINE compounds show efficacy in solid tumors, with ongoing research focusing on optimization and combination therapies.
  • Further research is essential to address safety concerns and identify predictive biomarkers for patient response.
Keywords:
XPO1XPO1 inhibitorcancerdrug resistance

More Related Videos

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking11:39

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Published on: October 23, 2019

11.4K
Analysis of mRNA Nuclear Export Kinetics in Mammalian Cells by Microinjection11:32

Analysis of mRNA Nuclear Export Kinetics in Mammalian Cells by Microinjection

Published on: December 4, 2010

15.3K

Related Concept Videos

Nuclear Export01:42

Nuclear Export

The nucleus restricts several proteins within and allows others to pass. The restricted proteins possess a nuclear retention sequence or NRS, anchoring them to the nuclear lamins and preventing their transport to the cytosol. The non-restricted proteins, after their synthesis, are transported to their site of action, such as the cytosol or other organelles, with the help of nuclear export signals or NES.
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
3.6K
Nuclear Protein Sorting01:34

Nuclear Protein Sorting

Nuclear protein sorting is the selective trafficking of histones, polymerases, gene regulatory proteins into the nucleus and exporting RNAs and ribosomes to the cytosol. It is a tightly controlled process that regulates gene expression within a cell.
Proteins targeted to the nucleus carry nuclear localization signals or NLS recognized by import receptors in the cytosol. Similarly, proteins with nuclear export signals are recognized by export receptors. Import and export receptors are...
4.6K
Nuclear Export of mRNA02:31

Nuclear Export of mRNA

4.5K
Directionality of Nuclear Transport01:42

Directionality of Nuclear Transport

Ras-related nuclear protein or Ran is a small G protein that cycles between its GTP and GDP bound states. Ran specific regulators, a Ran GTPase Activating Protein or RanGAP present in the cytosol and a Ran guanine nucleotide exchange factor or RanGEF present inside the nucleus regulate GTP/GDP exchange. A high concentration of GTP inside the cells, in addition to this asymmetric distribution of  Ran-specific regulators, leads to a higher RanGTP concentration inside the nucleus. This...
3.2K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
Nuclear Localization Signals and Import01:46

Nuclear Localization Signals and Import

Proteins targeted to the nucleus carry short stretches of amino acid sequences called the nuclear localization signal or NLS. Classical nuclear localization signals are of two types: monopartite and bipartite NLS. Monopartite classical NLS (cNLS) consists of a single cluster of 4-8 amino acids. Bipartite cNLS consists of two clusters of  2-3 amino acids and a 9-12 residue long proline-rich linker bridging the two clusters. Signal clusters are rich in positively charged amino acids such as...
5.7K